These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18313958)

  • 21. Cystic fibrosis: year in review.
    Boyle MP
    Curr Opin Pulm Med; 2010 Nov; 16(6):583. PubMed ID: 20829695
    [No Abstract]   [Full Text] [Related]  

  • 22. [Gene therapy of cystic fibrosis].
    Rochat T
    Schweiz Med Wochenschr; 1999 Nov; 129(46):1779-83. PubMed ID: 10603652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cystic fibrosis lung disease and its management].
    Hidaka N; Hidaka Y
    Nihon Rinsho; 1999 Sep; 57(9):2139-44. PubMed ID: 10497420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cystic fibrosis: from a single gene to complex pathophysiology.
    Kargul J; Irminger-Finger I
    Int J Biochem Cell Biol; 2014 Jul; 52():1. PubMed ID: 24792669
    [No Abstract]   [Full Text] [Related]  

  • 25. Cystic fibrosis, a multi-systemic mucosal disease: 25 years after the discovery of CFTR.
    Edelman A; Sallenave JM
    Int J Biochem Cell Biol; 2014 Jul; 52():2-4. PubMed ID: 24735713
    [No Abstract]   [Full Text] [Related]  

  • 26. [Problems posed by genetic diseases: cystic fibrosis].
    Bellon G; Reix P
    Rev Prat; 2006 Apr; 56(8):883-90. PubMed ID: 16764250
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cystic fibrosis in the adult patient].
    Nemitz I; Nicod L
    Rev Med Suisse; 2013 Aug; 9(395):1549-50. PubMed ID: 24024428
    [No Abstract]   [Full Text] [Related]  

  • 28. Cystic fibrosis and bone disease: defective osteoblast maturation with the F508del mutation in cystic fibrosis transmembrane conductance regulator.
    Velard F; Delion M; Le Henaff C; Guillaume C; Gangloff S; Jacquot J; Tabary O; Touqui L; Barthes F; Sermet-Gaudelus I
    Am J Respir Crit Care Med; 2014 Mar; 189(6):746-8. PubMed ID: 24628315
    [No Abstract]   [Full Text] [Related]  

  • 29. Gene therapy in cystic fibrosis.
    Prickett M; Jain M
    Transl Res; 2013 Apr; 161(4):255-64. PubMed ID: 23273902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy for cystic fibrosis: current issues.
    Southern KW
    Br J Hosp Med; 1996 Apr 17-30; 55(8):495-9. PubMed ID: 8732222
    [No Abstract]   [Full Text] [Related]  

  • 31. Cystic fibrosis: premature degradation of mutant proteins as a molecular disease mechanism.
    Gelman MS; Kopito RR
    Methods Mol Biol; 2003; 232():27-37. PubMed ID: 12840537
    [No Abstract]   [Full Text] [Related]  

  • 32. [New therapeutic approaches to Cystic fibrosis].
    Willemot JM; Sermet Gaudelus I; Lenoir G
    Ann Pharm Fr; 2003 Jul; 61(4):253-8. PubMed ID: 12843958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twenty years after cystic fibrosis gene identification: Where are we and what are we up to?
    Edelman A; Fritsch J; Ollero M
    Pathol Biol (Paris); 2011 Jun; 59(3):131-3. PubMed ID: 19896304
    [No Abstract]   [Full Text] [Related]  

  • 34. Understanding cystic fibrosis, improving life expectancy.
    Bentley P
    Nurs Times; 1999 Oct 27-Nov 2; 95(43):50-1. PubMed ID: 10847084
    [No Abstract]   [Full Text] [Related]  

  • 35. Homozygosity for L997F in a child with normal clinical and chloride secretory phenotype provides evidence that this cystic fibrosis transmembrane conductance regulator mutation does not cause cystic fibrosis.
    Derichs N; Schuster A; Grund I; Ernsting A; Stolpe C; Körtge-Jung S; Gallati S; Stuhrmann M; Kozlowski P; Ballmann M
    Clin Genet; 2005 Jun; 67(6):529-31. PubMed ID: 15857421
    [No Abstract]   [Full Text] [Related]  

  • 36. [Challenges of personalized medicine for cystic fibrosis].
    Corvol H; Taytard J; Tabary O; Le Rouzic P; Guillot L; Clement A
    Arch Pediatr; 2015 Jul; 22(7):778-86. PubMed ID: 26021452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Making precision medicine personal for cystic fibrosis.
    Manfredi C; Tindall JM; Hong JS; Sorscher EJ
    Science; 2019 Jul; 365(6450):220-221. PubMed ID: 31320522
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetic testing to provide targeted treatment for cystic fibrosis patients.
    Edelman A; Sermet-Gaudelus I; Rousset JP
    Pharmacogenomics; 2007 Sep; 8(9):1101-4. PubMed ID: 17924824
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pathophysiology and therapy of mucoviscidosis].
    Bachert C
    HNO; 1996 Apr; 44(4):167-8. PubMed ID: 8655345
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of cystic fibrosis gene mutations in determining susceptibility to chronic pancreatitis.
    Cohn JA; Mitchell RM; Jowell PS
    Gastroenterol Clin North Am; 2004 Dec; 33(4):817-37, vii. PubMed ID: 15528020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.